Polyrizon Ltd. — Investor Relations & Filings
Polyrizon Ltd. is a clinical-stage biotechnology company focused on the development and commercialization of innovative intranasal products. The company's core technology is based on proprietary hydrogels delivered as nasal sprays. Polyrizon is advancing two primary platforms: Capture & Contain™ (C&C), which creates a protective bioadhesive gel barrier in the nasal cavity to block airborne pathogens and allergens, and Trap & Target™ (T&T), a system designed for the targeted intranasal delivery of therapeutic drugs. The company's pipeline includes candidates for preventative treatments, such as allergy blockers, and drug delivery systems with potential applications for the central nervous system (CNS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-05-04 | English | |
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-27 | English | |
| 6-K - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-08 | English | |
| 424B5 - Polyrizon Ltd. (0001893645) (Filer) | 2026-04-08 | English | |
| 20-F/A - Polyrizon Ltd. (0001893645) (Filer) | 2026-03-27 | English | |
| 20-F - Polyrizon Ltd. (0001893645) (Filer) | 2026-03-25 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Polyrizon Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35346/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35346 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35346 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35346 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35346}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Polyrizon Ltd. (id: 35346)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.